logo

Europe Biobanks Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The market is segmented By Equipment, Media, Services, Application (Regenerative Medicine, Drug Discovery, and Disease Research) and Geography

Home Market Analysis Healthcare Research Biotechnology Research Bioservices Research Biobanks Research Europe Biobanks Market

Europe Biobanks Market Size

View Global Report
CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 6.50 %

Major Players

Europe Biobanks Market

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Europe Biobanks Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Europe Biobanks Market Analysis

Stem cell practices are on the rise in European countries and are contributing to the development of new solutions for various diseases. Several advancements have been made in regenerative medicine through stem cell technology over the past decade. Thus, it has become one of the vital treatment methods for diseases, such as Alzheimer's, diabetes, cancer, and rare genetic diseases. To benefit from the existing therapies, umbilical cord cells and other stem cells are preserved in Biobanks. The European Science Foundation (ESF) has been an active player in advancements made in stem cell and regenerative medicine research and in providing new treatments for incurable diseases and opportunities. With the increase in awareness about stem cell therapies, there have been a larger number of parents, who choose umbilical cord banks for their children. Biobanks not only aid in the therapies for genetic diseases, but also in medical research on rare genetic disorders. However, other factors such as rising burden of chronic diseases and R&D funding and investments by government and non-governmental organizations are also expected to drive the market in the forecast period.

Europe Biobanks Market Trends

This section covers the major market trends shaping the Europe Biobanks Market according to our research experts:

Alarm Monitoring Systems Segment is Expected to Show Better Growth in the Forecast Years

Based on Equipment, it is segmented into cryogenic storage system, alarm monitoring systems and other equipments. Stem cell banking is considered as one of the most promising and emerging fields. The cryogenic storage systems, freezers, refrigerators, and all other storage devices in a biobank require continuous monitoring of various processes. This is effectively done only with an alarm monitoring system. Alarms are used at various stages, from filling to continuous monitoring of temperature. Hence, with advancements in technology and the rising adoption of automated storage systems, there is high demand for automated alarm monitoring devices, which is expected to fuel the market growth.

Europe Biobanks Market 1

Europe Biobanks Industry Overview

The market is competitive and with the entrance of key players, the market is expected to grow due to increased competition amongst the existing players. For instance, Atlanta Biologicals Inc. (Bio-Techne Corporation), Becton, Dickinson and Company, BioLifeSolutions Inc., Hamilton Company, Qiagen N.V, , Stemcell Technologies Inc., Thermo Fisher Scientific, etc. are providing these products across the globe.

Europe Biobanks Market Leaders

  1. BioLifeSolutions Inc.

  2. Hamilton Company

  3. Sigma-Aldrich Inc. (Merck KGaA)

  4. Thermo Fisher Scientific Inc.

  5. VWR International LLC

*Disclaimer: Major Players sorted in no particular order

Europe Biobank Market 2.png
Need More Details on Market Players and Competitors?
Download PDF

Europe Biobanks Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Advancements in Stem Cell and Regenerative Medicine Research

      2. 4.2.2 Rising Burden of Chronic Diseases

      3. 4.2.3 R&D Funding and Investments by Government and Non-Governmental Organizations

    3. 4.3 Market Restraints

      1. 4.3.1 Regulatory Issues

      2. 4.3.2 Cost Constraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Equipment

      1. 5.1.1 Cryogenic Storage Systems

        1. 5.1.1.1 Refrigerators

        2. 5.1.1.2 Ice Machines

        3. 5.1.1.3 Freezers

      2. 5.1.2 Alarm Monitoring Systems

      3. 5.1.3 Other Equipment

    2. 5.2 Media

      1. 5.2.1 Optimized Media

      2. 5.2.2 Non-optimized Media

    3. 5.3 Services

      1. 5.3.1 Human Tissue Biobanking

      2. 5.3.2 Stem Cell Biobanking

      3. 5.3.3 Cord Banking

      4. 5.3.4 DNA/RNA Biobanking

      5. 5.3.5 Other Services

    4. 5.4 By Application

      1. 5.4.1 Regenerative Medicine

      2. 5.4.2 Drug Discovery

      3. 5.4.3 Disease Research

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Atlanta Biologicals Inc. (Bio-Techne Corporation)

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 BioLifeSolutions Inc.

      4. 6.1.4 Chart Industries Inc.

      5. 6.1.5 Hamilton Company

      6. 6.1.6 Qiagen NV

      7. 6.1.7 Sigma-Aldrich Inc. (Merck KGaA)

      8. 6.1.8 STEMCELL Technologies Inc.

      9. 6.1.9 Thermo Fisher Scientific Inc.

      10. 6.1.10 VWR International LLC

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Biobanks Industry Segmentation

As per the scope of the report, Biobanks are the bio-repository, wherein various biomaterials (usually human specimens) are stored for research purposes. This study targets gaining a detailed overview of the market dynamics of the contemporary biobank market during the forecast period. 

Equipment
Cryogenic Storage Systems
Refrigerators
Ice Machines
Freezers
Alarm Monitoring Systems
Other Equipment
Media
Optimized Media
Non-optimized Media
Services
Human Tissue Biobanking
Stem Cell Biobanking
Cord Banking
DNA/RNA Biobanking
Other Services
By Application
Regenerative Medicine
Drug Discovery
Disease Research
Need A Different Region Or Segment?
Customize Now

Europe Biobanks Market Research FAQs

The Europe Biobanks Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)

BioLifeSolutions Inc., Hamilton Company, Sigma-Aldrich Inc. (Merck KGaA), Thermo Fisher Scientific Inc. and VWR International LLC are the major companies operating in the Europe Biobanks Market.

The report covers the Europe Biobanks Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Biobanks Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Europe Biobanks Industry Report

Statistics for the 2024 Europe Biobanks market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Biobanks analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Europe Biobanks Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Europe Biobanks Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)